Esperion Therapeutics Inc (ESPR)
Healthcare
Drug Manufacturers - Specialty & Generic
3.20 $
+0.0%
vs. previous close
Closing price · As of: 15. Jul 2026
Esperion Therapeutics Inc (ESPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -28 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -25 | -19 | -37 | 54 | -7.2 | -35 | -35 | -23 | -31 | -4.3 | 45 | -28 | -18 | |
| 0.1 | 0.0 | 0.0 | 0.4 | 0.0 | -0.4 | 0.0 | 0.7 | 0.0 | 0.0 | 1.4 | 0.0 | 1.5 | |
| 3.2 | 3.0 | 2.9 | 3.2 | 2.9 | 3.0 | 2.8 | 2.5 | 2.7 | 2.3 | 2.4 | 2.5 | 9.9 | |
| 3.2 | 15 | – | – | – | – | – | – | – | – | – | – | – | |
| 10 | 6.6 | 4.0 | -22 | -5.0 | -12 | -21 | 12 | -26 | 21 | -21 | -1.1 | -28 | |
| 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.4 | |
| 18 | – | – | -0.1 | -0.1 | -0.2 | – | – | – | – | 0.2 | -0.2 | – | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | |
| -48 | 0.0 | 0.0 | – | -344 | 344 | – | – | – | – | – | – | – | |
| 0.8 | -4.3 | 4.5 | 91 | -30 | -9.1 | 35 | -7.5 | 2.9 | 11 | 30 | 16 | 60 | |
| -6.4 | -24 | -33 | 144 | -37 | -45 | 0.0 | -30 | -29 | 6.4 | 75 | -12 | 42 | |
| -25 | -19 | -37 | 54 | -7.3 | -35 | -35 | -23 | -31 | -4.3 | 45 | -28 | -18 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.